Evidence map›Paper›PMID 42433753›Full record

ArticleAnnals of medicine and surgery (2012)2026

High-grade, poorly differentiated breast carcinoma mimicking primary breast lymphoma: a case report of a diagnostic dilemma.

Sarada Khadka, Ashish Sapkota, Priyanka Regmi, Rajan Shah, Ishwor Tiwari, Dikshya Thadarai

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarada KhadkaDepartment of Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Ashish SapkotaDepartment of Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.ORCID https://orcid.org/0009-0008-7222-291X
Priyanka RegmiDepartment of Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Rajan ShahDepartment of Pathology, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Ishwor TiwariDepartment of Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
Dikshya ThadaraiDepartment of Surgery, Universal College of Medical Sciences (UCMS), Bhairahawa, Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-grade breast carcinomas can occasionally exhibit morphological and immunophenotypic features resembling hematolymphoid neoplasms, leading to diagnostic confusion. Accurate diagnosis is essential to guide appropriate therapy. Case presentation: We report a 35-year-old female presenting with a rapidly enlarging right breast mass. Core biopsy revealed sheets of atypical lymphoid-like cells. Immunohistochemistry (IHC) showed positivity for cytokeratin, progesterone receptor, CD10, CD117, and BCL2, while CD20, CD3, estrogen receptor, and HER2 were negative, with Ki-67 > 95%. Despite initial suspicion of primary breast lymphoma, the overall clinicopathologic correlation favored a diagnosis of high-grade, poorly differentiated invasive breast carcinoma. Discussion: This case highlights a rare diagnostic pitfall where breast carcinoma mimics lymphoma. Careful histopathologic evaluation, comprehensive IHC profiling, and clinicopathologic correlation are crucial to avoid misdiagnosis and ensure timely management. Conclusion: Awareness of such mimicry can prevent unnecessary hematolymphoid-directed therapy.

Indexed as

breast carcinomadiagnostic dilemmahigh-grade carcinomaimmunohistochemistryprimary breast lymphoma mimic

Identifiers

PMID42433753
PMCPMC13354356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.